Akebia Therapeutics Inc (NASDAQ:AKBA)

2.27
Delayed Data
As of 3:59pm ET
 -0.07 / -3.00%
Today’s Change
2.25
Today|||52-Week Range
13.71
-64.16%
Year-to-Date

Today’s Trading

Previous close2.34
Today’s open2.35
Day’s range2.26 - 2.37
Volume392,353
Average volume (3 months)5,597,081
Market cap$330.5M
Data as of 3:59pm ET, 10/29/2020

Growth & Valuation

Earnings growth (last year)+4.52%
Earnings growth (this year)+7.94%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)+61.26%
P/E ratioNM
Price/Sales2.23
Price/Book0.72

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...+0.18+1.90%
CNCEConcert Pharmaceutic...-0.28-2.50%
OVIDOvid Therapeutics In...+0.09+1.84%
ACIUAC Immune SA+0.06+1.28%
Data as of 3:59pm ET, 10/29/2020

Financials

Next reporting dateNovember 5, 2020
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$335.0M
Annual profit (last year)-$279.7M
Net profit margin-83.48%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts